Comparative Pharmacology
Head-to-head clinical analysis: HALFLYTELY versus HEPTALAC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HALFLYTELY versus HEPTALAC.
HALFLYTELY vs HEPTALAC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PEG 3350 is an osmotic agent that causes water retention in the colon, leading to bowel evacuation. Electrolytes (sodium sulfate, potassium chloride, magnesium sulfate, sodium bicarbonate) prevent significant electrolyte shifts.
Ammonia scavenger; lactulose is metabolized by colonic bacteria to organic acids, acidifying the colon, which converts NH3 to NH4+ and promotes ammonia excretion. Lactulose also reduces colonic transit time and bacterial production of ammonia.
Oral: 1 liter (provided as powder for reconstitution) administered at a rate of 240 mL every 10 minutes until rectal effluent is clear or 4 liters total is consumed. Typically given as split-dose: half the volume the evening before and half the morning of colonoscopy.
Oral: 3.33 g (30 mL) 3 times daily. Rectal: 200 mL of 30% solution as retention enema, 3 times daily. Intravenous: 30 g as a single dose via intra-abdominal instillation.
None Documented
None Documented
Not applicable; PEG 3350 is not significantly absorbed and does not have a systemic half-life. The colon transit time is approximately 1 hour after ingestion.
Terminal elimination half-life is 6-12 hours in patients with normal hepatic function; prolonged in hepatic encephalopathy due to altered clearance (up to 24 hours).
Primarily fecal elimination of unabsorbed PEG 3350; negligible systemic absorption <0.06%. Electrolytes are excreted renally and fecally.
Primarily renal (approximately 70-80%) as unchanged drug; minor biliary/fecal elimination (20-30%).
Category C
Category C
Laxative
Laxative